Arthur B. Sanders, M.D., M.H.A. N Engl J Med 2011; 365:850-851September 1, 2011
Out-of hospital cardiac arrest accounts for more than 330,000 deaths annually in the United States and Canada. Despite regular updates of guidelines for the management of these arrests, the rate of survival has been stagnant at 7.6% for more than 30 years.1,2 In this issue of the Journal, the Resuscitation Outcomes Consortium reports the results of two randomized comparisons3,4 from the Prehospital Resuscitation Impedance Valve and Early Versus Delayed Analysis (ROC PRIMED) trial (ClinicalTrials.gov number, NCT00394706), which evaluated potential improvements in the management of out-of hospital cardiac arrest.
The first component of the ROC PRIMED trial compared two . . .
Weblink here